申请人:CSPC Zhongqi Pharmaceutical Technology
(Shijiazhuang) Co., Ltd.
公开号:EP3190111A1
公开(公告)日:2017-07-12
Disclosed are a compound of formula (I), a tautomer, an optical isomer or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing the above-mentioned compounds. The above-mentioned compounds have the activity of inhibiting Xa factor positive effect, and can be used for the preparation of a medicament for preventing and/or treating diseases inhibiting Xa factor positive effect in case of low bleeding risk.
本发明公开了一种式(I)化合物、其同分异构体、光学异构体或药学上可接受的盐,以及含有上述化合物的药物组合物。上述化合物具有抑制 Xa 因子阳性作用的活性,可用于制备预防和/或治疗低出血风险情况下抑制 Xa 因子阳性作用的疾病的药物。